CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected...

36
CTE AND MRE: CTE AND MRE: WHO, HOW, WHAT, WHY WHO, HOW, WHAT, WHY Joel F. Platt, M.D. University of Michigan

Transcript of CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected...

Page 1: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE AND MRE:CTE AND MRE:WHO, HOW, WHAT, WHYWHO, HOW, WHAT, WHY

Joel F. Platt, M.D.University of Michigan

Page 2: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

OBJECTIVESOBJECTIVES

Review basics of performing CTE and MRE

Identify key imaging findings with CTE and MRE

Discuss factors that may influence choice of CTE vs MRE

Page 3: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

IMAGING OF SMALL BOWELIMAGING OF SMALL BOWEL

NeoplasmObstructionIBDIschemiaTrauma

Page 4: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTECTEWHAT IS IT?WHAT IS IT?

MDCTSingle or dual phase scanningLow attenuation oral contrastIV contrastAxial and 3DFocus on bowel

Page 5: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTECTE

CT exam focused on small bowel

CT exam optimized for small bowel

Page 6: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE ORAL CONTRASTCTE ORAL CONTRASTIMPORTANT CHOICEIMPORTANT CHOICE

IntrinsicWaterLAOCMilk and others

Page 7: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE TECHNIQUE: CTE TECHNIQUE: ORAL CONTRASTORAL CONTRAST

VoLumen administration:– 6 hours fasting prior to scan– 1350 ml 3 bottles of 450 ml over 90 min

• 450 ml 90 min• 450 ml 45 min• 225 ml 20 min• 225 ml 5 min

Young B et al; JCAT 2008Kuehle CA et al; AJR 2006

Page 8: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

MAYO ORAL CONTRASTMAYO ORAL CONTRASTRegimen

Time Contrast0 min 1 bottle Volumen (450 cc)

15 min 1 bottle Volumen (450 cc)30 min 1 bottle Volumen (450 cc)45 min 1 bottle H20 (500 cc)58 min +/- 0.5 mg Glucagon IV60 min - scan

Page 9: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

““SELFSELF”” PREPPED PATIENTPREPPED PATIENT

A new observation with VoLumen not seen with bright oral agentsSeen with active bowel disease Crohns, infections, malabsorption, obstructionGives appearance of good VoLumen prep

Page 10: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE DELAY TIME CTE DELAY TIME

40 sec vs 70 secNo advantage for CTE1 Phase is sufficient70 sec preferred

Vandenbroucke et al, Acta Radiology 2007

Page 11: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTECTEOPTIMAL SCAN DELAYOPTIMAL SCAN DELAY

50 sec delay 14 sec after aortic peakEnteric phase better than arterial5 ml/sec injection rate

Schindera et al, Radiology 2007

Page 12: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

RADIATION DOSE IN CTERADIATION DOSE IN CTE

Often young patients

Often need repeat imaging

Low dose CTE vs MRE

Page 13: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

MRE PROTOCOL (1.5 T)MRE PROTOCOL (1.5 T)3-plane localizerAxial and coronal T2W single-shot fast spin-echo SSFSE (HASTE)axial & coronal steady-state free precession FIESTA (B-TFE)Coronal pre and post contrast 3D SPGR-LAVA (THRIVE) with fat-saturationAxial delayed postcontrast 2D SPGR-LAVA (THRIVE) with fat-saturation

Page 14: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

MR PULSE SEQUENCESMR PULSE SEQUENCEST2-weighted (single –shot techniques)– HASTE, SSFSE, SSTSE– Fat suppression? Improves conspicuity of ↑ SI

bowel wall and mesenteric fat, but diminished discrimination of bowel wall

Contrast enhanced 3D gradient echo sequence– FAME, VIBE, THRIVE– Fat suppression: yes

May use balanced GRE– FIESTA, TruFISP, Balanced FFE

Employ parallel imaging

Page 15: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

MRE MRE PedsPeds Protocol Protocol –– PrescanPrescanNPO – only if sedated examPt arrives 90 minutes before exam start timeOral prep:– 2-3 bottles of VoLumen “CT” oral contrast material over 60-90

minutes– 8 oz water immediately prior to scan

• VoLumen & water are both biphasic (T1W hypo- intense & T2W hyperintense)

Glucagon administered as split dose (smooth muscle relaxant) – 0.25-0.5 mg IV immediately prior to localization– 0.25-0.5 mg IV immediately prior to postcontrast imaging

Page 16: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

MRE MRE PedsPeds Protocol Protocol –– SequencesSequencesC.S. Mott Children’s Hospital (1.5T)– 3-plane localizer & parallel imaging reference scans– T2W single-shot fast spin-echo (SSFSE)

• axial & coronal– Balanced steady-state free precession (SSFP)

• axial & coronal– Diffusion-weighted echo-planar (EPI)

• axial– T2W fast spin-echo (FSE) with fat-saturation

• axial– Dynamic postcontrast 3D SPGR (THRIVE) with fat-saturation

• coronal– Delayed postcontrast 3D SPGR (THRIVE) with fat-saturation

• axial & coronal

Page 17: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

MDCT OF IBDMDCT OF IBD

DiagnosisDifferentialActivityComplications

Page 18: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE FOR IBD WHY NOW?CTE FOR IBD WHY NOW?

16 slice or beyond MDCT

Water/Volumen for oral contrast

Volume visualization/workstation

Aggressive medical therapy for IBD

Page 19: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTECTEGOOD QUESTIONSGOOD QUESTIONS

Known IBD, ? disease activityKnown stricture,? medical vs surgical treatment

Complications from IBD

Page 20: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CROHNCROHN’’S STRICTURES STRICTUREMANAGEMENTMANAGEMENT

Inflammatory– Medical therapy – steroids, anti-TNFA

agents---- side effects

Fibrotic– Surgical treatment

Page 21: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTECTEQUESTIONABLE INDICATIONQUESTIONABLE INDICATION

R/O IBDShort term F/U after treatmentDifferentiate types of bowel disease

Page 22: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

MDCT FOR IBDMDCT FOR IBD

Mucosal/wall enhancement

Local vascularity

Extraluminal complications

Anastomotic disease

Page 23: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE OF CROHNS ACTIVECTE OF CROHNS ACTIVE

Mural enhancementMural stratificationThick bowelSTSEngorged vasa rectaObstruction

Paulsen et al, Radiographics 2006

Page 24: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE FEATURES OF ACTIVE CTE FEATURES OF ACTIVE CROHNS DISEASE CROHNS DISEASE

Mural thickening: – > 3 mm in distended bowel

Mural hyperenhancement: – Visual assessment in comparison with adjacent loops

Mural stratification: – Enhancing mucosa and serosa with hypodense

submucosa due to edemaWall thickening associated with hyper-enhancement is the most sensitive sign of active disease*

*Booya F et al; Radiology 2006

Page 25: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE OF ACTIVE IBDCTE OF ACTIVE IBD

Mesenteric changes:– Mesenteric fat stranding– Prominence and engorgement of vasa

recta “comb sign”Mesenteric changes are the most specificCT finding for active CD and correlate with levels of C reactive protein*

*Colombel JF et al; Gut 2006

Page 26: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE IN CROHNS DISEASECTE IN CROHNS DISEASECTE has reported sensitivity of 80 – 90% for detection of active Crohn disease1

Higher specificity as compared to capsule endoscopy (89% vs 53%)2

CTE can identify intramural inflammation in 24% of patients with normal appearing mucosa on ileoscopy3

CTE changed gastroenterologist’s impression of steroid benefit in 61% of patients4

Booya A et al; Abdominal Imaging 2008 2. Solem CA et al; Gastrointest Endosc 2008 3. Siddiki H et al RSNA 2008 4. Higgins PD et al Inflamm Bowel Dis 2008

Page 27: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE CTE MONITOR CROHNMONITOR CROHN’’S STATUSS STATUS

40 exams (20 patients)CTE correlated with symptoms in 80%Symptoms could get worse with stable/improved CTERadiation/MRE

Haara et al, AJR 2008

Page 28: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE vs SURGICAL PROOFCTE vs SURGICAL PROOF

36 patientsStricture, Fistula, AbscessCTE highly accurate compared to proofSearch for multiple fistula and strictures

Vogel et al, Dis Colon Rectum 2007

Page 29: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

MRE ADVANTAGESMRE ADVANTAGESNo ionizing radiation– Young patients– Life long disease– Life long imaging

Complete evaluation– Bowel– Extraenteric

Superior contrast resolution

Page 30: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

MRE DISADVANTAGESMRE DISADVANTAGES

Scanner timeLabor intensiveExpenseWorse spatial resolution than CTMore unpredictable

Page 31: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE vs MRECTE vs MRE

26 patients CTE = MRE for more advanced dzMRE better for milder dzComplications seen by both

Low, JMRI 2000

Page 32: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE vs MRECTE vs MREIppolito et al. (Abdom Imaging 2009):– Compared MRE vs. CTE agreement in 29 pts

• wall thickening (kappa=1)• mucosal hyperenhancement (kappa=1)• CTE superior to MRE for detection of mesenteric fibrofatty proliferation &

lymphadenopathy (p<0.05)• MRE superior in visualization of fistulae

–– CONCLUSION:CONCLUSION: MRE is accurate in monitoring activity of CD compared to CTE and may be considered an alternative to CTE in assessing degree of CD and evaluating therapeutic effectiveness

Page 33: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE vs MRECTE vs MRESiddiki et al. (AJR 2009):– 30 pts with suspected Crohn evaluated with CTE, MRE, and

ileoscopy– MRE & CTE sensitivities for detection of small bowel Crohn disease

similar (90.5% vs 95.2%; p=0.32)– MRE & CTE both identified 8 cases active small bowel inflammation

in which endoscopy was normal

–– CONCLUSIONS:CONCLUSIONS:• MRE & CTE have similar sensitivities for detecting active small bowel

inflammation• Cross-sectional enterography provides added information to endoscopy

Page 34: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE vs MRECTE vs MRELee et al. (Radiology 2009):– 31 pts with suspected Crohn evaluated with CTE, MRE, SBFT, and

ileoscopy– No differences in ability to detect active terminal ileitis between

modalities (p>0.017)– Sensitivity for detection of extra-enteric complications were higher for

CTE / MRE (100% for both, p<0.001)

–– CONCLUSION:CONCLUSION: Because MRE has a diagnostic effectiveness comparable to CTE, this technique has potential to be used as a radiation-free alternative for evaluation of patients with CD

Page 35: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE vs MRECTE vs MRE

Learning curveTechniqueResolutionCostRadiationAvailability

Page 36: CTE AND MRE: WHO, HOW, WHAT, WHY · CTE vs MRE Siddiki et al. (AJR 2009): – 30 pts with suspected Crohn evaluated with CTE, MRE, and ileoscopy – MRE & CTE sensitivities for detection

CTE/MRE SMALL BOWELCTE/MRE SMALL BOWELSUMMARYSUMMARY

With proper technique CTE/MRE can provide comprehensive evaluation of small bowelIncreasing role of imaging for obstruction, ischemia and IBD